Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.54 USD | +7.55% | +8.78% | +55.37% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.62M | Sales 2025 * | 4.94M | Capitalization | 361M |
---|---|---|---|---|---|
Net income 2024 * | -95M | Net income 2025 * | -120M | EV / Sales 2024 * | 58.3 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 59.4 x |
P/E ratio 2024 * |
-3.51
x | P/E ratio 2025 * |
-3.45
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.97% |
Latest transcript on Solid Biosciences Inc.
1 day | +7.55% | ||
1 week | +8.78% | ||
Current month | +7.55% | ||
1 month | -23.31% | ||
3 months | +34.56% | ||
6 months | +305.96% | ||
Current year | +55.37% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 9.54 | +7.55% | 175,841 |
24-04-30 | 8.87 | +0.91% | 171,145 |
24-04-29 | 8.79 | -2.12% | 113,767 |
24-04-26 | 8.98 | +5.15% | 189,872 |
24-04-25 | 8.54 | -2.62% | 378,947 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.37% | 361M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- SLDB Stock